New Products

Article

ThinPrep labeling expanded to glandular lesions detection

The Food and Drug Administration has approved an expansion of the labeling for ThinPrep Pap Test to include detection of endocervical and endometrial glandular lesions. The new labeling cites many peer-reviewed publications as demonstrating the test's biopsy-confirmed ability to better detect abnormal glandular findings compared to the conventional Pap smear. This means, according to Cytyc Corporation (Marlborough, Mass.), that a finding of a glandular abnormality on a ThinPrep Pap Test slide merits increased attention for definitive evaluation of potential endocervical or endometrial pathology. ThinPrep is the only cervical cancer screening technology to gain expanded labeling claims related to the detection of glandular abnormalities. Currently the most widely used method for cervical cancer screening in the United States, ThinPrep is also the only method approved by the FDA as "significantly more effective than the conventional Pap smear for the detection of low-grade squamous intraepithelial (LSIL) and more severe lesions in a variety of patient populations." In addition, the test is the only liquid-based cytology that's FDA approved for HPV testing and the only FDA-approved cytology system for chlamydia testing directly from the ThinPrep collection vial.

For more information, visit the company's Web site at http:// http://www.thinprep.com/.

For more information, contact the company by phone at 1-800-969-5483 or e-mail (medical@lumitex.com
) or visit the Web site at http:// http://www.lightmat.com/.

Depigmenting pump spray

For more information on Aclaro emulsion, call 1-800-499-4468 or visit the company's Web site at http:// http://www.aclaro4.com/ or http:// http://www.jsjpharm.com/.

Recent Videos
Dr. Somi Javaid highlights disparities in sexual health | Image Credit: hermd.com.
How advancements in IVF are impacting embryologist workload and patient care | Image Credit: fertility.coopersurgical.com/our_experts
Study finds no causal link between maternal health in pregnancy and autism risk | Image Credit: med.nyu.edu/faculty.
Mirvie's RNA platform revolutionizes detection of fetal growth restriction | Image Credit: wexnermedical.osu.edu
How early genetic testing empowers parents and improves outcomes | Image Credit: tuftsmedicine.org
Dallas Reed highlights trends and barriers in prenatal genetic testing | Image Credit: tuftsmedicine.org
How maternal fetal medicine specialists improve outcomes for high-risk pregnancies | Image Credit: profiles.mountsinai.org
How the cobas liat assay panels improve STI detection | Image Credit: labqualityconfab.
Screening-to-diagnosis interval vital for gestational diabetes outcomes | Image Credit: ultracon2024.eventscribe.net
Henri M. Rosenberg, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.